Achieve Life Sciences (ACHV) Current Leases (2010 - 2026)
Achieve Life Sciences (ACHV) posted Current Leases of $51000.0 for Q1 2026, down 16.39% on a QoQ basis from $61000.0 in Q4 2025, and down 10.53% year-over-year from $57000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Current Leases (2010 - 2026) Analysis & Trends
Achieve Life Sciences' Current Leases history runs 17 years deep, the most recent figure standing at $51000.0 for Q1 2026.
- Quarterly Current Leases fell 10.53% year-over-year to $51000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51000.0 (down 10.53% YoY) and the FY2025 annual result came in at $61000.0, up 10.91% from the prior year.
- Current Leases was $51000.0 for Q1 2026 at Achieve Life Sciences, down from $61000.0 in the prior quarter.
- Across five years, Current Leases topped out at $63000.0 in Q4 2023 and bottomed at $22000.0 in Q3 2024.
- A 5-year average of $51529.4 and a median of $58000.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases sank 66.67% — and 2025, when it jumped 168.18%.
- Achieve Life Sciences' Current Leases stood at $58000.0 in 2022, then rose by 8.62% to $63000.0 in 2023, then declined by 12.7% to $55000.0 in 2024, then increased by 10.91% to $61000.0 in 2025, then retreated by 16.39% to $51000.0 in 2026.
- Business Quant data shows ACHV's Current Leases at $51000.0 in Q1 2026, $61000.0 in Q4 2025, and $59000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | 51,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 57,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | 53,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 60,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Sep 30, 2022 | 23,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 59,000.00 |
| Dec 31, 2021 | 69,000.00 |
| Sep 30, 2021 | 69,000.00 |
| Jun 30, 2021 | 68,000.00 |